BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Regnite gabapentin enacarbil regulatory update

XenoPort said the drug evaluation committee in the Japanese Ministry of Health, Labor and Welfare (MHLW) recommended approval of Regnite gabapentin enacarbil to treat...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >